Advisory Board

Heidi Brown, MD, MAS, FACOG

Heidi Brown, MD, MAS, FACOG is an Assistant Professor at the University of Wisconsin School of Medicine and Public Health, board-certified in Obstetrics and Gynecology and Female Pelvic Medicine and Reconstructive Surgery.

Dr. Brown graduated magna cum laude from Brown University’s Program in Liberal Medical Education with a Bachelor’s degree in Community Health and obtained her medical degree from Warren Alpert Medical School at Brown University in 2006.

She completed a fellowship in Applied Epidemiology with the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia in 2005.

After her residency in Obstetrics and Gynecology at the University of Pittsburgh Medical Center, Magee-Women’s Hospital, she completed fellowship in Female Pelvic Medicine and Reconstructive Surgery and obtained a Masters of Advanced Studies in Clinical Research at the University of California – San Diego.

She joined the faculty at UW-Madison in 2013 and holds appointments in the Department of Obstetrics and Gynecology and the Department of Urology. Dr. Brown’s primary research focus is on improving access to effective treatments for pelvic floor disorders (urinary incontinence, bowel incontinence, and pelvic organ prolapse) for women across the lifespan, with a particular focus on those who may not seek medical care.

She currently holds research funding from the National Institutes of Health, the Wisconsin Partnership Program, and the University of Wisconsin’s Institute for Clinical and Translational Research.

Consultant Urologist Mr Laurence Stewart

Mr Laurence Stewart graduated from Aberdeen University Medical School in 1982. He gained a wide experience across all surgical disciplines before training in Urology in Aberdeen and Belfast and subsequently specialising in female and reconstructive urology in Cardiff, Christchurch New Zealand and Duke University in North Carolina USA. He took up his current post as Consultant Urological Surgeon in 1996 and has introduced a wide range of reconstructive treatments to Edinburgh.

He was a research fellow in Belfast for two years, studying bladder cancer, achieving his MD thesis in 1994. He has published widely on this and other urological topics. He has authored the chapter on Urological Surgery in Principles and Practice of Surgery and co-authored the chapter on Kidney and Genito-Urinary Disease in Davidson’s principles and practice of Medicine. He retains an active interest in training and is the convener of the Core skills in Urology course in the Royal College of Surgeons in Edinburgh.

He was the Lead clinician for Urology in Edinburgh from 1998 to 2007, during which time he helped establish minimal access surgery and promoted the role for laser prostatectomy and specialist physiotherapy in both male and female urinary incontinence.
His clinical interests are in reconstructive urology and urinary incontinence and he is a member of the Scientific Committee of International Continence Society 2009 – 2013 being Chairman in 2011.

He is the Co-Chair, Section of Lichen Sclerosus in Urethral disease: for the International Consultation on Urological Disease (ICUD)

Laurence is a member of the British Association of Urological Surgeons (BAUS), the British Medical Association (BMA) and the International Continence Society (ICS)

Dr David Templeton

Dr David Templeton serves as Non-Executive Chairman at N4 Pharma Plc since May 3, 2017. An experienced R&D manager having worked in major pharmaceutical, biotech and in the generic industry with specific expertise in early clinical development and translational biology, toxicology and safety pharmacology, lead selection, candidate characterisation, PK/PD analysis and bioanalysis. David has worked in various pharmacology and pre-clinical drug discovery roles for Pfizer, Xenova, Smithkline Beecham and GSK and was the head of non-clinical development at Celltech Limited from 2003 to 2004 before moving to Merck Generics UK as head of biometrics. He was appointed as director of clinical pharmacology of Eisai Limited in 2007 until in 2010 setting up his own consulting business offering discovery and early development advice to several pharmaceutical companies.